Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Synta Pharmaceuticals Corp (NASDAQ:SNTA)

0.3934
Delayed Data
As of May 05
 +0.0046 / +1.18%
Today’s Change
0.15
Today|||52-Week Range
2.65
+11.76%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization169.0K168.0K166.0K159.0K
 
 
 
 
 
 
Operating ExpensesGross Income-169.0K-168.0K-166.0K-159.0K
 
 
 
 
 
General Expenses20.2M19.3M17.2M10.2M
 
 
 
 
 
Research And Development16.2M16.4M14.4M7.2M
 
 
 
 
 
Total Operating Expenses20.3M19.5M17.4M10.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.3M-19.5M-17.4M-10.4M
 
 
 
 
 
Interest Expense On Debt375.0K296.0K234.0K156.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.7M-19.8M-17.6M-10.5M
 
 
 
 
 
Net Income-20.7M-19.8M-17.6M-10.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS108.4M132.3M136.0M137.3M
 
 
 
 
 
Shares To Calculate EPS Diluted108.4M132.3M136.0M137.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.19-$0.15-$0.13-$0.08
 
 
 
 
 
EPS Diluted-$0.19-$0.15-$0.13-$0.08